Segment Outlooks

Segment‑level outlooks: the Healthcare unit is expected to achieve an 8.1 % YoY revenue gain, driven by its continued strong growth trend. The Applied Sterilization Technologies (AST) segment is projected to grow organically and benefit from rising bioprocessing demand. Life Sciences is anticipated to uphold the robust expansion seen in consumables and service revenues from the previous quarter.